Tech Times of New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Times of New York.

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

Press releases published on December 8, 2025

Dec. 8, 2025

Nick Lawless Reveals the Future of ‘Lawless Leadership’ in Exclusive Xraised Interview

EIN Presswire

Dec. 8, 2025

Sustainable Media Center Announces 2025 Social Media Heroes Awards

EIN Presswire

Dec. 8, 2025

In New York’s Overloaded Dating Scene, New Matchmaking Service MYA Bets on Safety and Serious Intentions

EIN Presswire

Dec. 8, 2025

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – TLX

GlobeNewswire

Dec. 8, 2025

“LEQEMBI®” (lecanemab) for the Treatment of Early Alzheimer’s Disease Included in China’s Commercial Insurance Innovative Drug List

GlobeNewswire

Dec. 8, 2025

ROSEN, NATIONAL TRIAL ATTORNEYS, Encourages Wildermuth Fund Mutual Fund Investors to Secure Counsel Before Important Deadline in Securities Class Action – WESFX, WEFCX, WEIFX

GlobeNewswire

Dec. 8, 2025

Imviva Biotech Presents Validating Data for CAR-T Cell Therapies CTD402 and CTA311 in Five Presentations at the 67th American Society of Hematology Annual Meeting

GlobeNewswire

Dec. 8, 2025

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against DexCom and CarMax and Encourages Investors to Contact the Firm

GlobeNewswire

Dec. 8, 2025

Imviva Biotech Presents Clinical Breakthroughs for CTD402 in High-Mortality T-Cell and Myeloid Leukemias at the 67th American Society of Hematology Annual Meeting

GlobeNewswire

Dec. 8, 2025

SYNOPSYS CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Synopsys, Inc. and Encourages Investors to Contact the Firm

GlobeNewswire

Dec. 8, 2025

IREN Closes $2.3 Billion Convertible Notes Offering and the Repurchase of Existing Convertible Notes

GlobeNewswire

Dec. 8, 2025

SKG Unveils Top Tech Wellness Gifts for Christmas 2025 – Revolutionary Neck & Foot Massagers for Instant Pain Relief

GlobeNewswire

Dec. 8, 2025

Netcapital Inc. Announces Appointment of Rich Wheeless as CEO

GlobeNewswire

Dec. 8, 2025

Nayax Announces Preliminary Results of Notes and Warrants Offering in Israel to Qualified Investors

GlobeNewswire

Dec. 8, 2025

Exicure Presents Positive Topline Phase 2 Data for Burixafor in Multiple Myeloma at 2025 ASH Annual Meeting

GlobeNewswire

Dec. 8, 2025

Hungry Hippo Fairing Successfully Qualified: Rocket Lab Clears Significant Milestone on Path to First Neutron Launch

GlobeNewswire

Dec. 8, 2025

Microchip Technology to Present at the Barclays 23rd Annual Global Technology Conference

GlobeNewswire

Dec. 8, 2025

Latham Group Appoints Sean Gadd as Chief Executive Officer

GlobeNewswire

Dec. 8, 2025

Oportun to Present at Sidoti December Virtual Investor Conference

GlobeNewswire

Dec. 8, 2025

Achieve Life Sciences Announced Granting of New Hire Inducement Awards

GlobeNewswire